Angelman & Rett Syndrome: Interaction and Communication

Communication Clinical Trial

Official title:

Parent-child Interaction and Communication in Families Who Have a Child With Rett Syndrome or Angelman Syndrome

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03720028
• Other study ID #: Snummer
• Status: Completed
• Start date: December 1, 2018
• Est. completion date: July 1, 2020

Study information

• Verified date: October 2018
• Source: Universitaire Ziekenhuizen Leuven
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

We aim to describe the communicative and sensory profile of children with Angelman syndrome or Rett syndrome and their use of augmentative and alternative communication. In addition, parents are surveyed regarding parent-child interaction and access to communication support.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 20
• Est. completion date: July 1, 2020
• Est. primary completion date: October 1, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 1 Year to 14 Years

Eligibility

Inclusion Criteria:

• Angelman or Rett syndrome

Exclusion Criteria:

• none

Related Conditions & MeSH terms

• Behavior, Child
• Communication
• Parent-Child Relations
• Rett Syndrome

Intervention

Behavioral:
• Observation
Describe communication and sensory profile using standardized tests and observations.
• Parental experiences
Survey parents' experiences with parent-child interaction and augmentative and alternative communication.

Locations

Country	Name	City	State
Belgium	Katholieke Universiteit Leuven	Leuven	Vlaams-Brabant

Sponsors (2)

Lead Sponsor	Collaborator
Universitaire Ziekenhuizen Leuven	KU Leuven

Country where clinical trial is conducted

Belgium, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Communication profile	Scores on language tests	1 day One-time measurement
Primary	Parent interaction	Scores on social tests	1 day One-time measurement